Figure legends
Figure 1. Flowchart for selection of the study patients
Figure 2. The cumulative incidence rate of arterial thromboembolic event (A), ischemic stroke (B), extracranial arterial thromboembolic events (C), cardiovascular death (D) and all-cause mortality (E) after propensity score matching comparing patients with venous thromboembolism and those with atrial fibrillation.
Figure 3. The cumulative incidence rate of arterial thromboembolic event (A), ischemic stroke (B), extracranial arterial thromboembolic events (C), cardiovascular death (D) and all-cause mortality (E) after propensity score matching comparing patients with deep vein thrombosis alone and those with atrial fibrillation.
Figure 4. The cumulative incidence rate of arterial thromboembolic event (A), ischemic stroke (B), extracranial arterial thromboembolic events (C), cardiovascular death (D) and all-cause mortality (E) after propensity score matching comparing patients with pulmonary embolism alone and those with atrial fibrillation.
Figure 5: The cumulative incidence rate of arterial thromboembolic event (A), ischemic stroke (B), extracranial arterial thromboembolic events (C), cardiovascular death (D) and all-cause mortality (E) after propensity score matching comparing patients with pulmonary embolism alone and those with deep vein thrombosis alone.
Figure 6. The incidence of arterial thromboembolic events and mortality between VTE and AF cohorts. The incidence of ischemic stroke and myocardial infarction were lower in VTE cohort than AF cohort but ECATE, particularly in low extremity, was lower in AF cohort than VTE cohort. In terms of mortality, CV death was lower in VTE cohorts than AF cohort while all-cause mortality and non-CV death were lower in AF cohort than VTE cohort. Abbreviation: AF: atrial fibrillation, CV: cardiovascular; ECATE: extracranial arterial thromboembolic event; VTE: venous thromboembolism.